Basit öğe kaydını göster

dc.contributor.authorHirschberg, Angelica Linden
dc.contributor.authorBitzer, Johannes
dc.contributor.authorCano, Antonio
dc.contributor.authorCeausu, Iuliana
dc.contributor.authorChedraui, Peter
dc.contributor.authorDurmuşoğlu, Fatih
dc.contributor.authorErkkola, Risto
dc.contributor.authorGoulis, Dimitrios G.
dc.contributor.authorKiesel, Ludwig
dc.contributor.authorLopes, Patrice
dc.contributor.authorPines, Amos
dc.contributor.authorvan Trotsenburg, Mick
dc.contributor.authorLambrinoudaki, Irene
dc.contributor.authorRees, Margaret
dc.date.accessioned2021-06-17T08:49:21Z
dc.date.available2021-06-17T08:49:21Z
dc.date.issued2021en_US
dc.identifier.citationHirschberg, A. L., Bitzer, J., Cano, A., Ceausu, I., Chedraui, P., Durmuşoğlu, F. ... Rees, M. (2021). Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide. Maturitas, 148, 55-61. https://dx.doi.org/10.1016/j.maturitas.2021.04.005en_US
dc.identifier.issn0378-5122
dc.identifier.issn1873-4111
dc.identifier.urihttps://dx.doi.org/10.1016/j.maturitas.2021.04.005
dc.identifier.urihttps://hdl.handle.net/20.500.12511/7210
dc.description.abstractIntroduction: Vulvovaginal atrophy (VVA) is a chronic condition caused by estrogen deficiency. It affects around 50% of postmenopausal women, reducing their general and sexual quality of life as well as the quality of their personal relationships. Aim: The aim of this clinical guide is to set out an individualized approach to the management of VVA with topical estrogens and non-hormonal preparations. Materials and methods: Literature review and consensus of expert opinion. Summary recommendations: An individualized approach is required for the management of VVA. Topical low-dose estrogens are effective and also alleviate urinary incontinence and prevent recurrent urinary tract infections. Women should not be denied long-term use of topical estrogens as long as they feel that this treatment is of benefit to them, because the safety data are reassuring. Non-hormonal preparations (lubricants and moisturizers) should be the first-line treatment for VVA in women taking adjuvant endocrine therapies for cancers considered to be hormone-dependent. They can be used over the long term.en_US
dc.description.sponsorshipSistema de Investigacion y Desarrollo (SINDE) ; Vice-Rectorado de Investigacion & Postgrado (VRIP) of the Universidad Catolica de Santiago de Guayaquil, Guayaquil, Ecuadoren_US
dc.language.isoengen_US
dc.publisherElsevier Ireland Ltden_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectNon-Hormonal Preparationsen_US
dc.subjectTopical Estrogensen_US
dc.subjectVulvovaginal Atrophyen_US
dc.titleTopical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guideen_US
dc.typearticleen_US
dc.relation.ispartofMaturitasen_US
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kadın Hastalıkları ve Doğum Ana Bilim Dalıen_US
dc.authorid0000-0003-4067-7887en_US
dc.identifier.volume148en_US
dc.identifier.startpage55en_US
dc.identifier.endpage61en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1016/j.maturitas.2021.04.005en_US
dc.identifier.wosqualityQ1en_US
dc.identifier.scopusqualityQ1en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster